JPY 1926.0
(0.34%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -74.42 Billion | -1466.58 Billion | 462.41 Billion | 2608.22 Billion | 213.74 Billion | 41.61 Billion |
Net Income | 23.04 Billion | 25.73 Billion | 33.23 Billion | 31.17 Billion | 30.59 Billion | 34.01 Billion |
Depreciation & Amortization | 8.11 Billion | 8.08 Billion | 8.78 Billion | 8.84 Billion | 9.26 Billion | 9.48 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -92.89 Billion | -1437.01 Billion | 480.9 Billion | 2606 Billion | 153.93 Billion | 38.51 Billion |
Other non-cash items | 3.53 Billion | -63.38 Billion | -60.5 Billion | -37.8 Billion | 19.94 Billion | -40.39 Billion |
Investing Cash Flow | 83.64 Billion | 367.72 Billion | -82.65 Billion | -231.37 Billion | -32.83 Billion | 184.94 Billion |
Investments in PPE | -22.84 Billion | -7.25 Billion | -9.79 Billion | -4.85 Billion | -4.72 Billion | -5.9 Billion |
Acquisitions | 742 Million | -1.99 Billion | -1.25 Billion | -1.17 Billion | -414 Million | -1.32 Billion |
Investment purchases | -472.98 Billion | -437.53 Billion | -963.26 Billion | -945.72 Billion | -1036.49 Billion | -725.93 Billion |
Sales/Maturities of investments | 606.41 Billion | 812.57 Billion | 890.11 Billion | 718.92 Billion | 1012.58 Billion | 916.06 Billion |
Other Investing Activities | 1.11 Billion | 1.94 Billion | 1.55 Billion | 1.45 Billion | -3.78 Billion | 2.04 Billion |
Financing Cash Flow | 188.36 Billion | -10.98 Billion | -14.48 Billion | -12.07 Billion | -12.76 Billion | -47.69 Billion |
Debt repayment | -156.16 Billion | -1398.47 Billion | -239.98 Billion | -1798.99 Billion | -210.36 Billion | -40 Billion |
Dividends payments | -5.7 Billion | -5.6 Billion | -5.88 Billion | -6.69 Billion | -7.38 Billion | -7.37 Billion |
Common Stock Repurchased | -9.37 Billion | -5.37 Billion | -8.6 Billion | -5.37 Billion | -5.38 Billion | -8 Million |
Common Stock Issuance | - | 1092.72 Billion | -645.06 Billion | -1798.99 Billion | -433.27 Billion | - |
Other Financing Activities | -1 Million | 305.74 Billion | 885.05 Billion | 3597.97 Billion | 643.63 Billion | -308 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -209.97 Billion | -1437.01 Billion | 480.9 Billion | 2606 Billion | 153.93 Billion | -220.79 Billion |
Cash at beginning of period | 4341.64 Billion | 5451.45 Billion | 5086.14 Billion | 2721.35 Billion | 2553.23 Billion | 2374.35 Billion |
Cash at end of period | 4540.39 Billion | 4341.64 Billion | 5451.45 Billion | 5086.14 Billion | 2721.35 Billion | 2553.23 Billion |
Capital Expenditure | -22.84 Billion | -7.25 Billion | -9.79 Billion | -4.85 Billion | -4.72 Billion | -5.9 Billion |
Effect of forex changes on cash | 41 Million | 30 Million | 36 Million | 19 Million | -23 Million | 8 Million |
Net cash flow / Change in cash | 198.75 Billion | -1109.81 Billion | 365.3 Billion | 2364.79 Billion | 168.11 Billion | 178.87 Billion |
Free Cash Flow | -97.27 Billion | -1473.84 Billion | 452.61 Billion | 2603.36 Billion | 209.01 Billion | 35.71 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 7.45 Billion | 2.06 Billion | 23.04 Billion | 4.89 Billion | 11.55 Billion | 4.53 Billion |
Depreciation & Amortization | - | - | 8.11 Billion | 2.12 Billion | 1.96 Billion | 1.85 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -92.89 Billion | - | - | - |
Other non-cash items | -7.45 Billion | -2.06 Billion | 3.53 Billion | -4.89 Billion | -11.55 Billion | -4.53 Billion |
Investing Cash Flow | - | - | 83.64 Billion | - | - | - |
Investments in PPE | - | - | -22.84 Billion | - | - | - |
Acquisitions | - | - | 742 Million | - | - | - |
Investment purchases | - | - | -472.98 Billion | - | - | - |
Sales/Maturities of investments | - | - | 606.41 Billion | - | - | - |
Other Investing Activities | - | - | 1.11 Billion | - | - | - |
Financing Cash Flow | - | - | 188.36 Billion | - | - | - |
Debt repayment | - | - | -156.16 Billion | - | - | - |
Dividends payments | - | - | -5.7 Billion | - | - | - |
Common Stock Repurchased | - | - | -9.37 Billion | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -1 Million | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | -209.97 Billion | - | - | - |
Cash at beginning of period | - | - | 4341.64 Billion | - | - | - |
Cash at end of period | - | - | 4540.39 Billion | 4.25 Billion | 3.92 Billion | 3.7 Billion |
Capital Expenditure | - | - | -22.84 Billion | - | - | - |
Effect of forex changes on cash | - | - | 41 Million | - | - | - |
Net cash flow / Change in cash | - | - | 198.75 Billion | 4.25 Billion | 3.92 Billion | 3.7 Billion |
Free Cash Flow | - | - | -97.27 Billion | 4.25 Billion | 3.92 Billion | 3.7 Billion |
POND
1721
TRUE
DRUG
HAIN
3090